New York S 1618: Enacts the "New York affordable drug manufacturing act"

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S01618 Summary:

BILL NOS01618 

&nbsp

SAME ASSAME AS A03236

&nbsp

SPONSORRIVERA

&nbsp

COSPNSRBROUK, CLEARE, COMRIE, COONEY, GONZALEZ, JACKSON, LIU, MAY

&nbsp

MLTSPNSR

&nbsp

Add Art 2-A Title IV §§282 - 285, Pub Health L

&nbsp

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

Go to top S01618 Actions:

BILL NOS01618 

&nbsp

01/13/2025REFERRED TO HEALTH

01/21/2025REPORTED AND COMMITTED TO FINANCE

04/29/20251ST REPORT CAL.750

04/30/20252ND REPORT CAL.

05/01/2025ADVANCED TO THIRD READING 

05/20/2025PASSED SENATE

05/20/2025DELIVERED TO ASSEMBLY

05/20/2025referred to health

01/07/2026died in assembly

01/07/2026returned to senate

01/07/2026REFERRED TO HEALTH

02/04/2026REPORTED AND COMMITTED TO FINANCE

02/09/2026COMMITTEE DISCHARGED AND COMMITTED TO RULES

02/09/2026ORDERED TO THIRD READING CAL.293

02/24/2026PASSED SENATE

02/24/2026DELIVERED TO ASSEMBLY

02/24/2026referred to health

Go to topS01618 Committee&nbspVotes:

Go to topS01618 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS01618 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 1618

 2025-2026 Regular Sessions

 IN SENATE

 January 13, 2025
 ___________

 Introduced by Sens. RIVERA, COONEY, MAY -- read twice and ordered print-
 ed, and when printed to be committed to the Committee on Health

 AN ACT to amend the public health law, in relation to enacting the "New
 York affordable drug manufacturing act"

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Short title. This act shall be known and may be cited as
 2 the "New York affordable drug manufacturing act".
 3 § 2. Article 2-A of the public health law is amended by adding a new
 4 title IV to read as follows:
 5 TITLE IV
 6 NEW YORK AFFORDABLE DRUG MANUFACTURING ACT
 7 Section 282. Definitions.
 8 283. Partnerships; production and distribution of generic
 9 prescription drugs.
 10 284. Reporting.
 11 285. Proprietary information.
 12 § 282. Definitions. As used in this title, the following terms shall
 13 have the following meanings:
 14 1. "Generic prescription drug" means a drug that is approved pursuant
 15 to an application submitted under subdivision (j) of section 355 of the
 16 Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 301 et seq.), or a
 17 biosimilar, as defined under the federal Public Health Service Act (42
 18 U.S.C. Sec. 262) that is not under patent.
 19 2. "Partnerships" means agreements for the procurement of generic
 20 prescription drugs by way of contracts or purchasing by a payer, state
 21 governmental agency, group purchasing organization, nonprofit organiza-
 22 tion, or other entity.
 23 § 283. Partnerships; production and distribution of generic
 24 prescription drugs. 1. (a) The commissioner shall enter into partner-
 25 ships, consistent with paragraph (b) of subdivision two of this section,

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD04133-01-5

 S. 1618 2

 1 in consultation with all appropriate state agencies and the department
 2 of health or equivalent institution of any other state as determined by
 3 the commissioner, to increase competition, lower prices, and address
 4 shortages in the market for generic prescription drugs, to reduce the
 5 cost of prescription drugs for public and private purchasers, taxpayers,
 6 and consumers, and to increase patient access to affordable drugs.
 7 (b) The department shall have the ability to hire staff to oversee and
 8 project-manage the partnerships for manufacturing or distribution of
 9 generic prescription drugs.
 10 2. (a) The commissioner shall enter into partnerships resulting in the
 11 production or distribution of generic prescription drugs, with the
 12 intent that these drugs be made widely available to public and private
 13 purchasers, facilities licensed pursuant to article